Empagliflozin prevents doxorubicin-induced myocardial dysfunction.
Sabatino J, De Rosa S, Tammè L, Iaconetti C, Sorrentino S, Polimeni A, Mignogna C, Amorosi A, Spaccarotella C, Yasuda M, Indolfi C.
Sabatino J, et al. Among authors: iaconetti c.
Cardiovasc Diabetol. 2020 May 15;19(1):66. doi: 10.1186/s12933-020-01040-5.
Cardiovasc Diabetol. 2020.
PMID: 32414364
Free PMC article.